Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort.
Dirk von LewinskiLukas HeroldEva BachlHeiko BuggerTheresa GlantschnigEwald KolesnikNicolas VerheyenMartin BenediktMarkus WallnerFriederike von LewinskiAlbrecht SchmidtStefan HarbKlemens AblasserMichael SachererDaniel ScherrMartin ManningerSascha PätzoldJohannes GollmerAndreas ZirlikGabor G TothPublished in: Journal of clinical medicine (2023)
In a real-world cohort of patients with MI-related CS, only 38% of patients met the eligibility criteria of the ECLS-SHOCK trial. Thus, the impact of the use of VA-ECMO on outcome parameters in MI-related CS, as observed in the ECLS-SHOCK trial, may differ in a more heterogeneous real-world CS population of the PREPARE CS registry.
Keyphrases
- end stage renal disease
- phase iii
- clinical trial
- ejection fraction
- phase ii
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- extracorporeal membrane oxygenation
- randomized controlled trial
- tyrosine kinase
- metabolic syndrome
- intensive care unit
- open label
- drug induced
- mechanical ventilation